•
Mar 31, 2017

CRISPR Therapeutics Q1 2017 Earnings Report

Total Revenue
$2.7M
Previous year: $476K
+467.9%
EPS
-$0.54
Previous year: -$0.459
+17.5%
Gross Profit
-$12.1M
Previous year: -$5.54M
+118.6%
Cash and Equivalents
$289M
Previous year: $201M
+44.0%
Total Assets
$322M

CRISPR Therapeutics

CRISPR Therapeutics